Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction
Yoshiya Tanaka, Satoshi Soen, Naoki Ishiguro, Hisashi Yamanaka, Toshiyuki Yoneda, Sakae Tanaka, Takeshi Ohira, Takaya Nitta, Naoki Okubo, Harry Genant, Desirée van der Heijde, Tsutomu Takeuchi
RMD Open Jul 2020, 6 (2) e001249; DOI: 10.1136/rmdopen-2020-001249